id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-E-0278-0016,FDA,FDA-2007-E-0278,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-11-13T05:00:00Z,2013,11,2013-11-13T05:00:00Z,,2013-11-13T13:49:43Z,,0,0,09000064814795a0
FDA-2007-E-0278-0015,FDA,FDA-2007-E-0278,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-10-31T04:00:00Z,2013,10,2013-10-31T04:00:00Z,,2013-10-31T12:03:34Z,,0,0,09000064814682a9
FDA-2007-E-0278-0014,FDA,FDA-2007-E-0278,U.S. Patent and Trademark Office Office - Letter,Other,Letter(s),2013-10-30T04:00:00Z,2013,10,2013-10-30T04:00:00Z,,2013-10-30T19:08:14Z,,0,0,0900006481467eb6
FDA-2007-E-0278-0013,FDA,FDA-2007-E-0278,"FDA/CDER to Covington & Burling LLP (Merck & Co., Inc.) - Letter",Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T14:23:52Z,,0,0,090000648119d5dc
FDA-2007-E-0278-0012,FDA,FDA-2007-E-0278,U.S. Patent & Trademark Office to Covington & Burling LLP - Letter,Other,Letter(s),2012-12-17T05:00:00Z,2012,12,2012-12-17T05:00:00Z,,2012-12-17T23:57:34Z,,0,0,090000648119028f
FDA-2007-E-0278-0011,FDA,FDA-2007-E-0278,Covington & Burling LLP - Letter,Other,Letter(s),2012-06-08T04:00:00Z,2012,6,2012-06-08T04:00:00Z,,2012-06-08T18:44:24Z,,0,0,09000064810121bc
FDA-2007-E-0278-0010,FDA,FDA-2007-E-0278,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-06-04T04:00:00Z,2012,6,2012-06-04T04:00:00Z,,2024-03-15T10:57:59Z,,0,0,090000648102e5b4
FDA-2007-E-0278-0009,FDA,FDA-2007-E-0278,"FDA/CDER to Covington & Burling LLP (Merck & Co., Inc.) - Letter",Other,Letter(s),2012-04-17T04:00:00Z,2012,4,2012-04-17T04:00:00Z,,2012-04-17T18:28:22Z,,0,0,0900006480ff2969
FDA-2007-E-0278-0008,FDA,FDA-2007-E-0278,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-03-12T04:00:00Z,2012,3,2012-03-12T04:00:00Z,,2012-03-12T15:42:59Z,,0,0,0900006480fd3be7
FDA-2007-E-0278-0006,FDA,FDA-2007-E-0278,Determination of Regulatory Review Period for Purposes of Patent Extension; ZOLINZA,Notice,N-Notice,2008-05-14T04:00:00Z,2008,5,2008-05-14T04:00:00Z,2008-07-15T03:59:59Z,2008-05-14T13:07:11Z,E8-10689,0,0,09000064805b7e34
FDA-2007-E-0278-0005,FDA,FDA-2007-E-0278,FDA Center for Drug Evaluation and Research to the USPTO - Letter,Other,LET-Letter,2008-05-12T04:00:00Z,2008,5,2008-05-12T04:00:00Z,,2008-05-12T22:41:51Z,,0,0,09000064805a699a
FDA-2007-E-0278-0004,FDA,FDA-2007-E-0278,USPTO to FDA Center for Drug Evaluation and Research - Letter,Other,LET-Letter,2008-05-12T04:00:00Z,2008,5,2008-05-12T04:00:00Z,,2008-05-12T22:41:49Z,,0,0,090000648050af17
FDA-2007-E-0278-0003,FDA,FDA-2007-E-0278,Sloan-Kettering Institute for Cancer Research - Patent Term Extension Application,Other,APP-Application,2008-05-12T04:00:00Z,2008,5,2008-05-12T04:00:00Z,,2013-08-11T04:20:11Z,,0,0,09000064805a68d5
FDA-2007-E-0278-0002,FDA,FDA-2007-E-0278,FDA Center for Drug Evaluation and Research to the USPTO - Letter,Other,LET-Letter,2007-05-16T04:00:00Z,2007,5,,,2008-05-12T22:21:30Z,,0,0,090000648042b417
FDA-2007-E-0278-0001,FDA,FDA-2007-E-0278,USPTO to FDA Center for Drug Evaluation and Research - Letter,Other,LET-Letter,2007-04-13T04:00:00Z,2007,4,,,2008-05-12T22:20:50Z,,0,0,090000648042b40a